Correlation Between Prestige Biologics and Dongbu Insurance

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Prestige Biologics and Dongbu Insurance at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Prestige Biologics and Dongbu Insurance into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Prestige Biologics Co and Dongbu Insurance Co, you can compare the effects of market volatilities on Prestige Biologics and Dongbu Insurance and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Prestige Biologics with a short position of Dongbu Insurance. Check out your portfolio center. Please also check ongoing floating volatility patterns of Prestige Biologics and Dongbu Insurance.

Diversification Opportunities for Prestige Biologics and Dongbu Insurance

0.72
  Correlation Coefficient

Poor diversification

The 3 months correlation between Prestige and Dongbu is 0.72. Overlapping area represents the amount of risk that can be diversified away by holding Prestige Biologics Co and Dongbu Insurance Co in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Dongbu Insurance and Prestige Biologics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Prestige Biologics Co are associated (or correlated) with Dongbu Insurance. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Dongbu Insurance has no effect on the direction of Prestige Biologics i.e., Prestige Biologics and Dongbu Insurance go up and down completely randomly.

Pair Corralation between Prestige Biologics and Dongbu Insurance

Assuming the 90 days trading horizon Prestige Biologics Co is expected to under-perform the Dongbu Insurance. In addition to that, Prestige Biologics is 1.71 times more volatile than Dongbu Insurance Co. It trades about -0.05 of its total potential returns per unit of risk. Dongbu Insurance Co is currently generating about -0.06 per unit of volatility. If you would invest  11,410,000  in Dongbu Insurance Co on October 5, 2024 and sell it today you would lose (1,150,000) from holding Dongbu Insurance Co or give up 10.08% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Prestige Biologics Co  vs.  Dongbu Insurance Co

 Performance 
       Timeline  
Prestige Biologics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Prestige Biologics Co has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long term up-swing for the company investors.
Dongbu Insurance 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Dongbu Insurance Co has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest weak performance, the Stock's basic indicators remain strong and the current disturbance on Wall Street may also be a sign of long term gains for the company investors.

Prestige Biologics and Dongbu Insurance Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Prestige Biologics and Dongbu Insurance

The main advantage of trading using opposite Prestige Biologics and Dongbu Insurance positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Prestige Biologics position performs unexpectedly, Dongbu Insurance can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Dongbu Insurance will offset losses from the drop in Dongbu Insurance's long position.
The idea behind Prestige Biologics Co and Dongbu Insurance Co pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.

Other Complementary Tools

Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Global Correlations
Find global opportunities by holding instruments from different markets